Genotype-Guided Dosing of Coumarin Derivatives: The European Pharmacogenetics of Anticoagulant Therapy (EU-PACT) Trial Design
Rianne MF van Schie(Utrecht University), Anke H. Maitland‐van der Zee(Utrecht University), Ann K. Daly(Newcastle University), Vangelis G. Manolopoulos(Laboratory of Molecular Genetics), Frits R. Rosendaal(Leiden University Medical Center), Ken Redekop(Erasmus University Rotterdam), Montserrat Briz(Hospital Sierrallana), Farhad Kamali(Newcastle University), Talitha I. Verhoef(Apple (Israel)), Anthonius de Boer(Utrecht University), Elisabeth Haschke‐Becher(Paracelsus Medical University), Rita Barallon, Mia Wadelius(Uppsala University), Julia Kirchheiner(Humboldt-Universität zu Berlin), Munir Pirmohamed(University of Liverpool)
Cited by 146
Related Papers
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Incidence and mortality of venous thrombosis: a population‐based study
|Journal of Thrombosis and Haemostasis|2007|1.4k
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study
|The Lancet|2011|1.3k
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
|The Lancet|1994|1.1k
Hyperhomocysteinemia as a Risk Factor for Deep-Vein Thrombosis
|New England Journal of Medicine|1996|1.1k